Patent Pools for ARVs: Industry Perspectives from ASPEN



Stavros Nicolaou*
Pharmacare Limited t/a Aspen, Building 7, Healthcare Park, Woodlands Drive, Woodmead, Sandton, P.O. Box 1593, Gallo Manor, 2052, South Africa


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 237
Abstract HTML Views: 175
PDF Downloads: 102
Total Views/Downloads: 514
Unique Statistics:

Full-Text HTML Views: 146
Abstract HTML Views: 106
PDF Downloads: 66
Total Views/Downloads: 318



© Stavros Nicolaou; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Pharmacare Limited t/a Aspen, Building 7, Healthcare Park, Woodlands Drive, Woodmead, Sandton, P.O. Box 1593, Gallo Manor, 2052, South Africa; Tel: +2711 239 3500/ +2711 239 6734; Fax: +2711 239 6018; E-mail:nicolaous@aspenpharma.com


Abstract

Affordability through reduced pricing is only one part of enhancing access to treatment in Public Health emergencies: Supply Security and the guarantee of supply consistency is the other.

To the extent that Patent Pooling is able to create Regional African Manufacturing capability, Africans will support the concept. However, to the extent that if further decentralises manufacture away from the continent and increases Africa’s dependence on imports, Patent Pooling can potentially weaken supply security and will continue to relegate Africa a Continent of dependency, rather than one that invests in its own capability.

Patent Pooling, should be viewed guardedly on the African Continent and will only be embraced, provided it is consistent with the AU Heads of State call for an African Manufacturing Plan and Africa’s aspiration to more from “converting charity dollars into sustainable, long term investment dollars”.